ACTUATE THERAPEUTICS, INC. — Form S-1/A
Filed October 14, 2026 · analyzed by the Registration Agent
S-1/A
▲ Likely positive
significance 78/100
What the filing says
Actuate Therapeutics filed an amended S-1 registration statement on October 14, 2026, registering up to 74,750,000 common shares, an underwriter warrant for 2,616,250 shares, and 2,616,250 underlying shares. Legal counsel (Greenberg Traurig) opined that all securities are duly authorized and validly issuable when paid for per registration terms. This represents the company's public equity offering for IPO purposes.
Why this rating
IPO registration with ~79.4M total shares represents massive dilution and funding event—likely multi-hundred-million dollar raise relative to $42.1M market cap. Transformational for pre-revenue biotech.
Tradability signal
NO TRADE
No trade: price $0.49 is below our $0.5 floor — spreads at this level eat any edge. (Filing arrived outside market hours — evaluated at the next open with a live quote.)
Derived from this site's own measured outcomes + live price/liquidity at analysis time. An experiment, not investment advice.
Price action (we called it positive)
at our read · unknown $0.48 | +10 min · unknown $0.47 ▼ 2.56% | +30 min · unknown $0.45 ▼ 5.94% | +1 hr · unknown $0.45 ▼ 5.94% | +4 hrs · unknown $0.45 ▼ 6.42% |
Quotes via Yahoo Finance at capture time; for filings arriving outside market hours the clock starts at the next open. Not investment advice. How accurate are our calls? →
See more from October 14, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.